COMMUNIQUÉS West-GlobeNewswire

Chemed Corporation Declares Quarterly Dividend of 70 Cents
06/08/2026
CINCINNATI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE ) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company’s capital stock, [...]
Genmab Announces Financial Results for the First Half of 2026
06/08/2026
August 6, 2026 Copenhagen, Denmark; Interim Report for the Six Months Ended June 30, 2026 Highlights Genmab announced positive Phase 3 results for epcoritamab plus lenalidomide in patients with relapsed/refractory [...]
Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
06/08/2026
Press Release – No. 14 / 2026 Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results Copenhagen, Denmark, August 6, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) ( [...]
ASHA To Present Its Annie Glenn Award To The Pitt
06/08/2026
TV Medical Drama Spotlights the Importance of Effective Communication Rockville, MD, Aug. 06, 2026 (GLOBE NEWSWIRE) -- The Pitt , a popular and highly regarded TV series, will receive the American Speech-Language- [...]
Kymanox Launches AI-Enabled Quality and Regulatory Capabilities for Life Sciences Organizations
06/08/2026
Built on a foundation of responsible artificial intelligence (AI) use with expert-verified deliverables, Kymanox can now apply AI to Quality Management System (QMS) development, batch release report review, and human [...]
Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms
06/08/2026
Newly Allowed Patent Protects Cell-Free MyeloCelz™ Exosome Technology Designed to Suppress Autoimmune Destruction of Insulin-Producing Cells, Reinforcing Creative Medical's Multi-Program Diabetes Strategy PHOENIX, Aug. [...]
Daré Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026
06/08/2026
SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world [...]
Spirited Paw® Healthy Mind By Standard Process® Named 2026 Senior Dog Nutrition Product of the Year
06/08/2026
The award recognizes Standard Process’ science-informed, whole food-based approach to supporting cognitive health in senior dogs PALMYRA, Wis., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Standard Process ® , a leader in whole [...]
Sonablate Announces Landmark Global Strategic Alliance with Eleven Ventures to Advance AI-Powered Precision Medicine
06/08/2026
Agreement establishes long-term commitment to support global expansion of Sonablate’s therapeutic ultrasound technology and facilitate up to $200 million in strategic capital formation JEDDAH, Saudi Arabia and CHARLOTTE [...]
Philips expands open patient monitoring ecosystem to help health systems keep sight of patients beyond the bedside
06/08/2026
August 6, 2026 New collaborations expand wearable and out-of-hospital monitoring capabilities, helping support continuous patient visibility from admission through recovery at home Amsterdam, Netherlands. – Royal [...]
Alpha Pro Tech, Ltd. Announces Second Quarter 2026 Financial Results
06/08/2026
Second Quarter Net Sales Increased by 12% to $18.7 Million from $16.7 Million in the Second Quarter of 2025; Second Quarter Net Income Increased by 47% to $1.8 Million from $1.2 Million in the Prior Year Period Net [...]
Kyntra Bio to Report Second Quarter 2026 Financial Results
06/08/2026
SAN FRANCISCO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio, Inc. (Nasdaq: KYNB) will announce second quarter 2026 financial results on Thursday, August 13 after market close. Kyntra Bio will also conduct a conference [...]
Sharecare launches AskMD nationwide to turn any health question into a personalized plan
06/08/2026
ATLANTA, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Sharecare today announced that AskMD, its AI-powered health navigation experience grounded in each individual’s medical history, health plan, and location, is now available [...]
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform
06/08/2026
Collaboration supports development of a next-generation AWS-native platform designed to accelerate commercialization, scalability and enterprise adoption SARASOTA, FLA., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Silo Pharma ( [...]
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
06/08/2026
ROSELAND, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that [...]
Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026
06/08/2026
ISELIN, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ (bevacizumab-vikg, bevacizumab gamma) [...]
SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026
06/08/2026
DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure [...]
Celcuity Schedules Release of Second Quarter 2026 Financial Results and Webcast/Conference Call
06/08/2026
MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a commercial-stage biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid [...]
Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
06/08/2026
Repeat dose of fasedienol demonstrated favorable safety and tolerability similar to single dose Efficacy signals were observed across primary and secondary endpoints in repeat dose and single dose Prespecified analysis [...]

Pages